February 18, 2025
The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio, aimed at driving cutting-edge rare disease breakthroughs, announces the appointment of Matthew Anderson, MD, PhD, as co-Director. Dr....
Continue ReadingJanuary 24, 2017
CLEVELAND: Two internationally recognized medical research leaders from University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine have received Outstanding Investigator Awards from the National Institutes of Health (NIH). The 7-year, $6.7 million dollar awards, which are the highest... Continue Reading
January 16, 2017
Cleveland, Ohio – The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, has announced the 2017 recipients of Harrington Scholar-Innovator Awards. The awards support breakthrough discoveries of physician-scientists whose research shows promise to advance the standard of care.The Harrington Discovery... Continue Reading
January 12, 2017
Cleveland, Ohio – Harrington Discovery Institute at University Hospitals in Cleveland, Ohio – part of The Harrington Project for Discovery & Development – has announced its 2016 partnership Scholars selected in collaboration with Alzheimer’s Drug Discovery Foundation (ADDF), and Foundation Fighting Blindness and... Continue Reading
January 10, 2017
CLEVELAND – Harrington Discovery Institute at University Hospitals in Cleveland, Ohio and the Alzheimer’s Drug Discovery Foundation (ADDF) have expanded their collaboration to accelerate translation of innovative research efforts for Alzheimer’s disease. Together, the two organizations will jointly market and administer a... Continue Reading
December 14, 2016
Cleveland, Ohio – 2016 Harrington Fellows have been selected by Harrington Discovery Institute. The new Harrington Fellows Award recognizes promising early- to mid-career physician-scientists in the greater Cleveland medical community and provides $75,000 per year for two years to support their research efforts.Harrington... Continue Reading
October 17, 2016
Cleveland, Ohio – Mukesh K. Jain, MD, University Hospitals Chief Scientific Officer, has been elected to the National Academy of Medicine, joining a distinguished organization that has made important contributions to health, medicine and science. This honor underscores Dr. Jain’s role in helping shape research and health... Continue Reading
August 15, 2016
Cleveland – The Trustees of the Burton D. Morgan Foundation in Hudson Ohio have awarded a grant of $200,000 to the Harrington Discovery Institute at University Hospitals in Cleveland, Ohio to support the Institute’s Innovation Support Center (ISC) and its mission of mentoring physician-scientists to advance novel... Continue Reading
June 13, 2016
LONDON AND CLEVELAND, OHIO, JUNE 13, 2016: Arix Bioscience Limited (Arix Bioscience), a global healthcare and life science company supporting medical innovation, announced today it has provided development capital to OptiKira, LLC (OptiKira), an early stage company developing drugs to help prevent blindness.Extensive research... Continue Reading
June 06, 2016
When the Lauder family founded the Alzheimer’s Drug Discovery Foundation (ADDF) in 1998, they knew that proprietary boundaries would only limit efforts to develop effective Alzheimer’s drugs. So they resolved to make the ADDF’s knowledge available to everyone working to overcome this devastating disease—and all the... Continue Reading
May 02, 2016
CLEVELAND AND INDIANAPOLIS – May 2, 2016 – BioMotiv, a drug development accelerator associated with the Harrington Project, and Indiana University Research and Technology Corp. announce the formation of a new biotechnology start-up, Allinaire Therapeutics. Allinaire Therapeutics aims to develop novel therapeutics for... Continue Reading